General
Preferred name
arformoterol
Synonyms
(R,R)-Formoterol tartrate ()
ARFORMOTEROL TARTRATE ()
Eformoterol Hemifumarate ()
YM 08316 ()
CGP 25827A ()
Formoterol Hemifumarate ()
FORMOTEROL ()
Symbicort-formoterol fumarate dihydrate ()
formoterol fumarate dihydrate ()
PT005 ()
(R, R)-Formoterol ()
(r,r)-formoterol ()
Formoterol r,r-form ()
(-)-formoterol ()
Brovana ()
Formoterol r,r-form l-tartrate ()
Arformoterol (tartrate) ()
P&D ID
PD009926
CAS
200815-49-2
43229-80-7
208102-40-3
73573-87-2
67346-49-0
1254575-18-2
Tags
available
drug
drug candidate
Approved by
FDA
First approval
2006
Drug indication
Chronic obstructive pulmonary disease
Asthma
Drug Status
approved
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Arformoterol is the active (R,R)-enantiomer of . The marketed product contains arformoterol tartrate (PubChem CID 9827062).
(GtoPdb)
PRICE
78
DESCRIPTION
High affinity dual ETA and ETB receptor antagonist;orally bioavailable
(Tocris Bioactive Compound Library)
DESCRIPTION
Arformoterol Tartrate ((R,R)-Formoterol tartrate) is the tartrate salt of arformoterol. Arformoterol is a long-acting beta-2 adrenergic agonist with bronchodilator activity[2].
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
1
Compound Sets
25
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
CZ-OPENSCREEN Bioactive Library
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP Approved Drugs
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
Mcule NIBR MoA Box Subset
Natural product-based probes and drugs
NCATS Inxight Approved Drugs
Novartis Chemogenetic Library (NIBR MoA Box)
NPC Screening Collection
Other bioactive compounds
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
Tocris Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
141
Molecular Weight
344.17
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
4
Rotatable Bonds
9
Ring Count
2
Aromatic Ring Count
2
cLogP
2.22
TPSA
90.82
Fraction CSP3
0.32
Chiral centers
2.0
Largest ring
6.0
QED
0.41
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
β2-adrenergic receptor
¦Â2-adrenergic receptor
Adrenergic Receptor
Primary Target
Adrenergic ?2 Receptors
MOA
Adrenergic Receptor agonist
Agonist
beta2-Adrenoceptor Agonist
Pathway
Neuronal Signaling
GPCR/G protein
Neuroscience
Member status
virtual
Biosynthetic Origin
Alkaloid
Therapeutic Indication
Bronchodilator
Therapeutic Class
Respiratory
Bronchodilator Agents
Source data

